Isolated microalbuminuria indicates a poor medical prognosis

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1794-1801

  Scheven, Lieneke ^a   Van Der Velde, Marije ^a   Heerspink, Hiddo J Lambers ^a   De Jong, Paul E ^a   Gansevoort, Ron T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Albuminuria; Cardiovascular outcome; Diabetes; Hypertension; Microalbuminuria

Indexed keywords

GLUCOSE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROALBUMINURIA; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

ALBUMINURIA; CARDIOVASCULAR OUTCOME; DIABETES; HYPERTENSION; MICROALBUMINURIA;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84884512939     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft031     Document Type: Article

References (24)

1. Chronic Kidney Disease Prognosis Consortium Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081
2. Gansevoort RT, Matsushita K, van der Velde M et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011; 80: 93-104
3. Astor BC, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative metaanalysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
4. van der Velde M, Matsushita K, Coresh J et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int 2011; 79: 1341-1352
5. Glassock RJ. Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 2010; 12: 364-368
6. Haynes R, Winearls C. Screening for risk with albuminuria: should we start from here? Nephrol Dial Transplant 2010; 25: 3463-3465
7. Stehouwer CD, Yudkin JS, Fioretto P et al. How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria. Nephrol Dial Transplant 1998; 13: 2751-2754
8. de Jager J, Dekker JM, Kooy A et al. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol 2006; 26: 1086-1093
9. Diercks GF, van Boven AJ, Hillege JL et al. The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol 2002; 18: 525-535
10. Halimi JM, Bonnet F, Lange C et al. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens 2008; 26: 2198-2206
11. Friedman AN, Marrero D, Ma Y et al. Value of urinary albuminto-creatinine ratio as a predictor of type 2 diabetes in pre-diabetic individuals. Diabetes Care 2008; 31: 2344-2348
12. Forman JP, Fisher ND, Schopick EL et al. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19: 1983-1988
13. Wang TJ, Evans JC, Meigs JB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370-1376
14. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008; 168: 897-905
15. Mahmoodi BK, Gansevoort RT, Veeger NJ et al. Microalbuminuria and risk of venous thromboembolism. JAMA 2009; 301: 1790-1797
16. Monster TB, Janssen WM, de Jong PE et al., PREVEND Study Group Prevention of REnal and Vascular ENT Stage Disease. Pharmacy data in epidemiological studies: an easy to obtain and reliable tool. Pharmacoepidemiol Drug Saf 2002; 11: 379-384
17. Brantsma AH, Bakker SJ, Hillege HL et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005; 28: 2525-2530
18. Brantsma AH, Bakker SJ, de Zeeuw D et al. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006; 17: 331-335
19. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969-975
20. van der Velde M, Bello AK, Brantsma AH et al. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? Nephrol Dial Transplant 2012; 27: 2275-2283
21. Forman JP, Scheven L, de Jong PE et al. Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 2012; 125: 3108-3116
22. Ritz E, Amann K, Koleganova N et al. Prenatal programmingeffects on blood pressure and renal function. Nat Rev Nephrol 2011; 7: 137-144
23. Williams B, Poulter NR, Brown MJ et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-185
24. Asselbergs FW, Diercks GF, Hillege HL et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004; 110: 2809-2816